Gene · 3738
Papers2,009
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,009
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Design and synthesis of novel small molecules targeting the Kv1.3 voltage-gated potassium ion channel. | Sci Rep | 2025 | 40993212 | PubTator, text mining | PubMed |
| NPY-functionalized niosomes for targeted delivery of margatoxin in breast cancer therapy. | Med Oncol | 2025 | 40924348 | PubTator, text mining | PubMed |
| Voltage-gated potassium channel isoform upregulation and functional alterations in multiple sclerosis peripheral blood mononuclear cells. | Int Immunopharmacol | 2025 | 40907330 | PubTator, text mining | PubMed |
| Kv1.3 Ion Channels Mediate Electrical Stimulation-Induced Collagen Expression in Human Dermal Fibroblasts. | Cosmetics | 2025 | 40893629 | PubTator, text mining | PubMed |
| Advances in diagnosis and patient profiling in pulmonary arterial hypertension for precision medicine. | Ther Adv Respir Dis | 2025 | 40878965 | PubTator, text mining | PubMed |
| A New Kv1.3 Channel Blocker from the Venom of the Ant Tetramorium bicarinatum. | Toxins (Basel) | 2025 | 40864056 | PubTator, text mining | PubMed |
| Functional role of Kv1.3 localization in chimeric antigen receptor T cells. | J Immunol | 2025 | 40849894 | PubTator, text mining | PubMed |
| Construction of a feature gene and machine prediction model for inflammatory bowel disease based on multichip joint analysis. | J Transl Med | 2025 | 40830794 | PubTator, text mining | PubMed |
| Anacyphrethines A and B as potent analgesics: Multiple ion channel inhibitors with an unprecedented chemical architecture. | Acta Pharm Sin B | 2025 | 40698126 | PubTator, text mining | PubMed |
| Targeting voltage-gated proton channel HV1: Optimised 5-phenyl-2-aminoimidazoles with anticancer potential. | Eur J Med Chem | 2025 | 40663975 | PubTator, text mining | PubMed |
| Mining of Targeted Therapeutic Drugs for Hepatocellular Carcinoma based on Programmed Cell Death-related Features and Construction of an Imaging Histology Diagnostic Model. | Curr Top Med Chem | 2025 | 40635214 | PubTator, text mining | PubMed |
| Exploration of the chemical space of benzamide-based voltage-gated potassium channel Kv1.3 inhibitors. | Acta Pharm | 2025 | 40608558 | PubTator, text mining | PubMed |
| Effects of β-adrenoceptor antagonist and 5-HT1A and 5-HT1B receptor antagonist alprenolol on human Kv1.3 currents. | Korean J Physiol Pharmacol | 2025 | 40605329 | PubTator, text mining | PubMed |
| Integrated analysis identifies key genes underlying the bidirectional association between depression and renal failure. | Sci Rep | 2025 | 40595897 | PubTator, text mining | PubMed |
| Unveiling new Kv1.3 channel blockers from scorpion venom: Characterization of Meuk7-3 and in silico design of its analogs for enhanced affinity and therapeutic potential. | Int J Biol Macromol | 2025 | 40533013 | PubTator, text mining | PubMed |
| Editorial: Insights in vascular physiology 2024. | Front Physiol | 2025 | 40510266 | PubTator, text mining | PubMed |
| De novo missense variants of KCNA3, KCNA4, and KCNA6 cause early onset developmental epileptic encephalopathy. | Hum Mol Genet | 2025 | 40472070 | PubTator, text mining | PubMed |
| Cellular and synaptic specializations for sub-millisecond precision in the mammalian auditory brainstem. | Front Cell Neurosci | 2025 | 40458470 | PubTator, text mining | PubMed |
| Disease-associated Kv1.3 Variants are Energy Compromised with Impaired Nascent Chain Folding. | J Mol Biol | 2025 | 40409708 | PubTator, text mining | PubMed |
| Role of CAR-T cell K+ channels in tumor infiltration and elimination. | J Immunol | 2025 | 40373182 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3738/papers?page=4